Progress of Photodynamic Therapy in Hepatocellular Carcinoma Using Nano/Microtechnology

Abstract

This article aims to examine the research advancements in photodynamic therapy (PDT) for hepatocellular carcinoma (HCC) utilizing nano/microtechnology. The objective is to provide valuable insights for disease prevention and control in patients with liver cancer (LC). LC is a prevalent form of cancer that inflicts significant suffering on patients. Early treatment plays a crucial role in improving the prognosis and enhancing the quality of life (QoL) for LC patients. While PDT has proven effective in treating surface and intracerebral tumors, studies focusing on intra-abdominal tumors, particularly liver tumors, are limited. Hence, it is essential to comprehend the clinical value and therapeutic outcomes of PDT for LC, particularly in the context of nano/microtechnology. With rapid advancements in nanotechnology, its integration into the medical field has grown extensively. By leveraging nanotechnology, the analysis of PDT’s effects on HCC yields significant clinical value. This article reviews the clinical diagnostic methods and therapeutic approaches for LC, emphasizes the impact of PDT on clinical outcomes for LC patients, and analyzes the progress of PDT applied to HCC under the framework of nano/microtechnology. The findings aim to offer valuable references for the clinical treatment of LC patients.